2018
DOI: 10.1093/annonc/mdy151.202
|View full text |Cite
|
Sign up to set email alerts
|

Survival and prognostic factors of non metastatic rectal adenocarcinoma: Analytic multifactor review of 91 cases

Abstract: and gender to gain more insight into tailored risk prediction and communication of risk to general practitioners (GPs) and/or participants. Methods: In this retrospective study, data was used of 57,421 participants who underwent a colonoscopy after a positive FIT in the Flemish CRC screening programme between October 2013 until July 2016. Analyses were performed with multinomial logistic regression to predict the probability of normal or noncancerous lesions, precancerous lesions, in situ or invasive cancers. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
5
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(6 citation statements)
references
References 0 publications
1
5
0
Order By: Relevance
“…The most common poor prognostic factor in all series is the low degree of differentiation compared to other histological types. It is found in about 34% of patients [28,29]. In our series, we had a low rate of poorly differentiated adenocarcinoma (2.40%).…”
Section: Prognostic Factors and Survivalmentioning
confidence: 41%
See 4 more Smart Citations
“…The most common poor prognostic factor in all series is the low degree of differentiation compared to other histological types. It is found in about 34% of patients [28,29]. In our series, we had a low rate of poorly differentiated adenocarcinoma (2.40%).…”
Section: Prognostic Factors and Survivalmentioning
confidence: 41%
“…It increased by 120% between stage II and stage III and reached 900% between stage III and stage IV. In the study by Arfa et al [29], stage IV had the lowest two-year survival rate (22.7%), while stages I and II had a better two-year survival rate (85.3%). Survival was reduced in patients with a right-sided colon tumor classified as stage III and IV in the study by Hu et al [30] (66.1% vs. 75.4%, p = 0.010).…”
Section: Prognostic Factors and Survivalmentioning
confidence: 90%
See 3 more Smart Citations